Enhanced oral bioavailability of felodipine by novel solid self-microemulsifying tablets

References

• Lindmark B, Ahnoff M, Persson BA. Enantioselective determination of felodipine in human plasma by chiral normal-phase liquid chromatography and electrospray ionisation mass spectrometry. J Pharm Biomed Anal 2002;27:489–95
   PubMed Web of Science ®Google Scholar
• Won DH, Kim MS, Lee S, et al. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int J Pharm 2005;301:199–208
   PubMed Web of Science ®Google Scholar
• Meng J, Li S, Yao Q, et al. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods. Drug Dev Ind Pharm 2014;40:929–36
   PubMed Web of Science ®Google Scholar
• Karavas E, Ktistis G, Xenakis A, Georgarakis E. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions. Drug Dev Ind Pharm 2005;31:473–89
   PubMed Web of Science ®Google Scholar
• Wu C, Zhao Z, Zhao Y, et al. Preparation of a push–pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core–shell structure. Int J Pharm 2014;475:298–305
   PubMed Web of Science ®Google Scholar
• Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci 2000;11:S93–8
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008;60:702–16
   PubMed Web of Science ®Google Scholar
• Cornaire G, Woodley J, Hermann P, et al. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 2004;278:119–31
   PubMed Web of Science ®Google Scholar
• Hauss DJ, Fogal SE, Ficorilli JV, et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci 1998;87:164–9
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Charman WN, Porter C. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev 2008;60:625–37
   PubMed Web of Science ®Google Scholar
• Rege B, Kao J, Polli J. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. J Pharm Sci 2002;16:237–46
   Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65–73
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm 2008;355:269–76
   PubMed Web of Science ®Google Scholar
• Holm R, Porter CJ, Edwards GA, et al. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci 2003;20:91–7
   PubMed Web of Science ®Google Scholar
• Ito Y, Kusawake T, Rama Prasad YV, et al. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies. Int J Pharm 2006;317:114–19
   PubMed Web of Science ®Google Scholar
• Yi T, Wan J, Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 2008;70:439–44
   PubMed Web of Science ®Google Scholar
• Nazzal S, Nutan M, Palamakula A, et al. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm 2002;240:103–14
   PubMed Web of Science ®Google Scholar
• Nazzal S, Khan MA. Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int J Pharm 2006;315:110–21
   PubMed Web of Science ®Google Scholar
• Wei LL, Li J, Guo LG, et al. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol. Drug Dev Ind Pharm 2007;33:990–8
   PubMed Web of Science ®Google Scholar
• Serratoni M, Newton JM, Booth S, Clarke A. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur J Pharm Biopharm 2007;65:94–8
   PubMed Web of Science ®Google Scholar
• Newton JM, Petersson J, Podczeck F, et al. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J Pharm Sci 2001;90:987–95
   PubMed Web of Science ®Google Scholar
• Abdalla A, Mader K. Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm 2007;66:220–6
   PubMed Web of Science ®Google Scholar
• Tuleu C, Newton M, Rose J, et al. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci 2004;93:1495–502
   PubMed Web of Science ®Google Scholar
• Li P, Ghosh A, Wagner RF, et al. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm 2005;288:27–34
   PubMed Web of Science ®Google Scholar
• Anuj GA, Ashok K, Paraag SG. Self emulsifying drug delivery system for enhanced solubility and dissolution of glipizide. Colloids Surfaces B Biointerfaces 2015;126:553–60
   PubMed Web of Science ®Google Scholar
• Hua XW, Lin C, Chen DX, et al. Sirolimus solid self-microemulsifying pellets: formulation development characterization and bioavailability evaluation. Int J Pharm 2012;438:123–33
   PubMed Web of Science ®Google Scholar
• Agarwal V, Siddiqui A, Ali H, Nazzal S. Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS). Int J Pharm 2009;366:44–52
   PubMed Web of Science ®Google Scholar
• Limnell T, Santos HA, Makila E, et al. Drug delivery formulations of ordered and non-ordered mesoporous silica: comparison of three drug loading methods. J Pharm Sci 2011;100:3294–306
   PubMed Web of Science ®Google Scholar
• Kinnari P, Makila E, Heikkila T, Salonen J. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int J Pharm 2011;414:148–56
   PubMed Web of Science ®Google Scholar
• Milovic M, Djuris J, Djekic L, et al. Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release. Int J Pharm 2012;436:58–65
   PubMed Web of Science ®Google Scholar
• Kallakunta VR, Bandari S, Jukanti R, Veerareddy PR. Oral self emulsifying powder of lercanidipine hydrochloride: formulation and evaluation. Powder Technol 2012;221:375–82
   Web of Science ®Google Scholar
• Heshmati N, Cheng X, Eisenbrand G, Fricker G, Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats. J Pharm Sci 2013;102:3792–9
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–20
   PubMed Web of Science ®Google Scholar
• Verma S, Singh SK, Verma PR, Ahsan MN. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box–Behnken design. Drug Dev Ind Pharm 2014;40:1358–70
   PubMed Web of Science ®Google Scholar
• Mountfield RJ, Senepin S, Schleimer M, et al. Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. Int J Pharm 2000;211:89–92
   PubMed Web of Science ®Google Scholar
• Hugger ED, Novak BL, Burton PS, et al. A comparison of commonly used polyetoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J Pharm Sci 2002;91:1991–2002
   PubMed Web of Science ®Google Scholar